Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression

Journal of Affective Disorders

Volumn 189, Issue , 2016, Pages 298-305

  Veen, Cato ^a   Myint, Aye Mu ^b   Burgerhout, Karin M ^a   Schwarz, Markus J ^c   Schütze, Gregor ^c   Kushner, Steven A ^a   Hoogendijk, Witte J ^a   Drexhage, Hemmo A ^a   Bergink, Veerle ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF MUNICH   (Germany)

^d AARHUS SCHOOL OF BUSINESS   (Denmark)

Author keywords

Depression; Immunology; Kynurenine; Postpartum; Psychosis; Serotonin; Tryptophan

Indexed keywords

3 HYDROXYKYNURENINE; 5 HYDROXYINDOLEACETIC ACID; KYNURENIC ACID; KYNURENINE; TRYPTOPHAN; 3-HYDROXYKYNURENINE;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; PUERPERAL PSYCHOSIS; PUERPERIUM; TANDEM MASS SPECTROMETRY; TRYPTOPHAN METABOLISM; ANALOGS AND DERIVATIVES; BLOOD; METABOLISM; PSYCHOSIS; PUERPERAL DISORDER; YOUNG ADULT;

ADULT; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; HYDROXYINDOLEACETIC ACID; KYNURENIC ACID; KYNURENINE; POSTPARTUM PERIOD; PSYCHOTIC DISORDERS; PUERPERAL DISORDERS; TANDEM MASS SPECTROMETRY; TRYPTOPHAN; YOUNG ADULT;

EID: 84943620715     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.09.064     Document Type: Article

References (47)

1. M.T. Abou-Saleh, R. Ghubash, L. Karim, M. Krymski, and D.N. Anderson The role of pterins and related factors in the biology of early postpartum depression Eur. Neuropsychopharmacol. 9 1999 295 300
2. A.B. Badaway The tryptophan utilization concept in pregnancy Obstet. Gynecol. Sci. 57 2014 249 259
3. A.B. Badawy Tryptophan: the key to boosting brain serotonin synthesis in depressive illness J. Psychopharmacol. 27 2013 878 893
4. D.A. Bender Biochemistry of tryptophan in health and disease Mol. Asp. Med. 6 1983 101 197
5. D.A. Bender Effects of a dietary excess of leucine and of the addition of leucine and 2-oxo-isocaproate on the metabolism of tryptophan and niacin in isolated rat liver cells Br. J. Nutr. 61 1989 629 640
6. V. Bergink, P. Boyce, and T. Munk-Olsen Postpartum psychosis: a valuable misnomer Aust. N. Z. J. Psychiatry 49 2015 102 103
7. V. Bergink, K.M. Burgerhout, K.M. Koorengevel, A.M. Kamperman, W.J. Hoogendijk, M.P. Lambregtse-van den Berg, and S.A. Kushner Treatment of psychosis and mania in the postpartum period Am. J. Psychiatry 172 2015 115 123
8. V. Bergink, K.M. Burgerhout, K. Weigelt, V.J. Pop, H. de Wit, R.C. Drexhage, S.A. Kushner, and H.A. Drexhage Immune system dysregulation in first-onset postpartum psychosis Biol. Psychiatry 73 2013 1000 1007
9. V. Bergink, M.P. Lambregtse-van den Berg, K.M. Koorengevel, R. Kupka, and S.A. Kushner First-onset psychosis occurring in the postpartum period: a prospective cohort study J. Clin. Psychiatry 72 2011 1531 1537
10. U. Boehm, T. Klamp, M. Groot, and J.C. Howard Cellular responses to interferon-gamma Annu. Rev. Immunol. 15 1997 749 795
11. P. Boyce, and E. Barriball Puerperal psychosis Arch. Womens Ment. Health 13 2010 45 47
12. L. Capuron, A. Ravaud, P.J. Neveu, A.H. Miller, M. Maes, and R. Dantzer Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy Mol. Psychiatry 7 2002 468 473
13. A. Chiarugi, M. Calvani, E. Meli, E. Traggiai, and F. Moroni Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages J. Neuroimmunol. 120 2001 190 198
14. First, M.B., Spitzer, Robert L., Gibbon Miriam, Williams, Janet B.W., 1996. Structured Clinical Interview for DSM-IV Axis I Disorders. Clinician Version (SCID-CV).
15. S. Fukui, R. Schwarcz, S.I. Rapoport, Y. Takada, and Q.R. Smith Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism J. Neurochem. 56 1991 2007 2017
16. N.I. Gavin, B.N. Gaynes, K.N. Lohr, S. Meltzer-Brody, G. Gartlehner, and T. Swinson Perinatal depression: a systematic review of prevalence and incidence Obstet. Gynecol. 106 2005 1071 1083
17. N. Gleicher Postpartum depression, an autoimmune disease? Autoimmun. Rev. 6 2007 572 576
18. S.L. Handley, T.L. Dunn, J.M. Baker, C. Cockshott, and S. Gould Mood changes in puerperium, and plasma tryptophan and cortisol concentrations Br. Med. J. 2 1977 18 20
19. M.M. Hughes, A. Carballedo, D.M. McLoughlin, F. Amico, A. Harkin, T. Frodl, and T.J. Connor Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation Brain Behav. Immun. 26 2012 979 987
20. J.P. Kim, and D.W. Choi Quinolinate neurotoxicity in cortical cell culture Neuroscience 23 1987 423 432
21. C. Kohl, T. Walch, R. Huber, G. Kemmler, G. Neurauter, D. Fuchs, E. Solder, H. Schrocksnadel, and B. Sperner-Unterweger Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues J. Affect. Disord. 86 2005 135 142
22. M. Maes, S. Bonaccorso, V. Marino, A. Puzella, M. Pasquini, M. Biondi, M. Artini, C. Almerighi, and H. Meltzer Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation Mol. Psychiatry 6 2001 475 480
23. M. Maes, R. Verkerk, S. Bonaccorso, W. Ombelet, E. Bosmans, and S. Scharpe Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation Life Sci. 71 2002 1837 1848
24. Y.V. Mándi, and L. Vécsei The kynurenine system and immunoregulation J. Neural Transm. 119 2012 197 209
25. T. Munk-Olsen, T.M. Laursen, C.B. Pedersen, O. Mors, and P.B. Mortensen New parents and mental disorders: a population-based register study JAMA 296 2006 2582 2589
26. A.M. Myint, Y.K. Kim, R. Verkerk, S.H. Park, S. Scharpe, H.W. Steinbusch, and B.E. Leonard Tryptophan breakdown pathway in bipolar mania J. Affect. Disord. 102 2007 65 72
27. A.M. Myint, Y.K. Kim, R. Verkerk, S. Scharpe, H. Steinbusch, and B. Leonard Kynurenine pathway in major depression: evidence of impaired neuroprotection J. Affect. Disord. 98 2007 143 151
28. A.M. Myint, M.J. Schwarz, and N. Muller The role of the kynurenine metabolism in major depression J. Neural Transm. 119 2012 245 251
29. A.M. Myint, M.J. Schwarz, R. Verkerk, H.H. Mueller, J. Zach, S. Scharpe, H.W. Steinbusch, B.E. Leonard, and Y.K. Kim Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naive and medication-free schizophrenic patients Brain Behav. Immun. 25 2011 1576 1581
30. S. Najjar, D.M. Pearlman, K. Alper, A. Najjar, and O. Devinsky Neuroinflammation and psychiatric illness J. Neuroinflamm. 10 2013 43
31. S. Ogawa, T. Fujii, N. Koga, H. Hori, T. Teraishi, K. Hattori, T. Noda, T. Higuchi, N. Motohashi, and H. Kunugi Plasma l-tryptophan concentration in major depressive disorder: new data and meta-analysis J. Clin. Psychiatry 75 2014 e906 e915
32. S. Okuda, N. Nishiyama, H. Saito, and H. Katsuki 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity J. Neurochem. 70 1998 299 307
33. S.K. Olsson, M. Samuelsson, P. Saetre, L. Lindstrom, E.G. Jonsson, C. Nordin, G. Engberg, S. Erhardt, and M. Landen Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder J. Psychiatry Neurosci. 35 2010 195 199
34. S.K. Olsson, C. Sellgren, G. Engberg, M. Landen, and S. Erhardt Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder Bipolar Disord. 14 2012 719 726
35. L.M. Osborne, and C. Monk Perinatal depression - the fourth inflammatory morbidity of pregnancy?: theory and literature review Psychoneuroendocrinology 38 2013 1929 1952
36. C.L. Raison, R. Dantzer, K.W. Kelley, M.A. Lawson, B.J. Woolwine, G. Vogt, J.R. Spivey, K. Saito, and A.H. Miller CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression Mol. Psychiatry 15 2010 393 403
37. J. Savitz, R. Dantzer, B.E. Wurfel, T.A. Victor, B.N. Ford, J. Bodurka, P.S. Bellgowan, T.K. Teague, and W.C. Drevets Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder Psychoneuroendocrinology 52 2015 200 211
38. J. Savitz, W.C. Drevets, C.M. Smith, T.A. Victor, B.E. Wurfel, P.S. Bellgowan, J. Bodurka, T.K. Teague, and R. Dantzer Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder Neuropsychopharmacology 40 2015 463 471
39. H. Schrocksnadel, G. Baier-Bitterlich, O. Dapunt, H. Wachter, and D. Fuchs Decreased plasma tryptophan in pregnancy Obstet. Gynecol. 88 1996 47 50
40. K. Schrocksnadel, B. Widner, A. Bergant, G. Neurauter, H. Schennach, H. Schrocksnadel, and D. Fuchs Longitudinal study of tryptophan degradation during and after pregnancy Life Sci. 72 2003 785 793
41. G.A.G. Schütze, T. Gschwendtner, and M.J. Schwarz Quantitative analysis of the kynurenine pathway Brain Behav. Immun. 29 2013 S21
42. R. Schwarcz, W.O. Whetsell Jr., and R.M. Mangano Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain Science 219 1983 316 318
43. V. Sharma, and D. Mazmanian The DSM-5 peripartum specifier: prospects and pitfalls Arch. Womens Ment. Health 17 2014 171 173
44. D. Sit, A.J. Rothschild, and K.L. Wisner A review of postpartum psychosis J. Womens Health (Larchmt) 15 2006 352 368
45. M.G. Spinelli Postpartum psychosis: detection of risk and management Am. J. Psychiatry 166 2009 405 408
46. M.C. Wichers, G.H. Koek, G. Robaeys, R. Verkerk, S. Scharpe, and M. Maes IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity Mol. Psychiatry 10 2005 538 544
47. P.A. Zunszain, C. Anacker, A. Cattaneo, S. Choudhury, K. Musaelyan, A.M. Myint, S. Thuret, J. Price, and C.M. Pariante Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis Neuropsychopharmacology 37 2012 939 949